The Centers for Medicare and Medicaid Services (CMS) issued a Request for Information (RFI) to solicit stakeholder feedback regarding regulatory changes impacting fraud, waste, and abuse in the healthcare industry as part of...more
3/4/2026
/ Centers for Medicare & Medicaid Services (CMS) ,
Comment Period ,
DMEPOS ,
Durable Medical Equipment ,
Enforcement Actions ,
Fraud Prevention ,
Healthcare Fraud ,
Medical Devices ,
Medicare ,
Medicare Advantage ,
Medicare Advantage Organizations (MAOs) ,
Medicare Fraud ,
Popular ,
Proposed Rules ,
Regulatory Reform ,
Regulatory Requirements ,
Request For Information ,
Surety Bonds
In a Notice to be published in the Federal Register on February 27, 2026, the Centers for Medicare and Medicaid Services (CMS) is imposing a nationwide (including all states, territories and the District of Columbia)...more
2/27/2026
/ Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
DMEPOS ,
Durable Medical Equipment ,
Enforcement Actions ,
Enrollment ,
Government Agencies ,
Health Care Providers ,
Healthcare Fraud ,
Medicaid ,
Medical Devices ,
Medicare ,
OIG ,
Regulatory Oversight ,
Regulatory Requirements
At the end of 2024, we predicted that the healthcare mergers and acquisitions (M&A) market would pick up steam in 2025, given the combination of decreasing interest rates, a potential shift in the regulatory landscape with...more
1/22/2026
/ Clinical Trials ,
Dental Practice ,
Digital Health ,
Health Care Providers ,
Health Insurance ,
Healthcare ,
Healthcare Facilities ,
Healthcare Reform ,
Hospital Mergers ,
Hospitals ,
Investment ,
Life Sciences ,
Merger Agreements ,
Pharmaceutical Industry ,
Physicians ,
Private Equity ,
Regulatory Reform ,
Regulatory Requirements ,
Reporting Requirements ,
Value-Based Care
As we rang in the new year and gathered in San Francisco for the 44th Annual J.P. Morgan Healthcare Conference, one theme consistently emerged: healthcare investing remains a market defined by contradiction....more
1/16/2026
/ Artificial Intelligence ,
Digital Health ,
Health Care Providers ,
Health Information Technologies ,
Healthcare Facilities ,
Home Health Agencies ,
Innovation ,
Investment ,
Investors ,
Life Sciences ,
Medicaid ,
Medicare ,
Pharmaceutical Industry ,
Private Equity ,
Private Equity Firms ,
Reimbursements ,
Value-Based Care
As we step into 2026, the healthcare private equity landscape is defined by both powerful momentum and meaningful constraints. Record levels of dry powder and a growing pipeline of high‑quality assets suggest increased deal...more
1/13/2026
/ ACOs ,
Acquisition Agreements ,
Artificial Intelligence ,
Corporate Practice of Medicine ,
EBITDA ,
Financing ,
Food and Drug Administration (FDA) ,
Hart-Scott-Rodino Act ,
Health Care Providers ,
Healthcare Facilities ,
Interest Rates ,
Investment ,
Investment Funds ,
Investors ,
Machine Learning ,
Merger Agreements ,
Pharmaceutical Industry ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds ,
Value-Based Care
Effective January 1, 2026, all Durable Medical Equipment, Prosthetic Devices, Prosthetics, Orthotics, and Supplies (DMEPOS) suppliers will be subject to the Centers for Medicare & Medicaid Services (CMS) 36-month rule...more
12/15/2025
/ Accreditation ,
Acquisition Agreements ,
Centers for Medicare & Medicaid Services (CMS) ,
DMEPOS ,
Durable Medical Equipment ,
Enrollment ,
Final Rules ,
Health Care Providers ,
Home Health Agencies ,
Life Sciences ,
Majority-Owned Affiliate (MOA) ,
Medicaid ,
Medical Devices ,
Medicare ,
Ownership Interest ,
Prospective Payment System (PPS) ,
Regulatory Oversight
Bass, Berry & Sims hosted the 15th annual Health Care Investors Conference (HCIC), co-sponsored by Deloitte, Gallagher and Houlihan Lokey, on October 29. Each year HCIC brings together hundreds of leading health care industry...more
11/13/2025
/ Artificial Intelligence ,
Digital Health ,
Due Diligence ,
Health Care Providers ,
Healthcare ,
Healthcare Reform ,
Home Health Agencies ,
Home Health Care ,
Hospice ,
Investment ,
Investors ,
Medicaid ,
Medicare ,
Mental Health ,
Popular ,
Private Equity ,
Private Equity Firms ,
Value-Based Payments
Though the long-term impact is yet to be seen, those wary of the changes to Medicaid eligibility and the Affordable Care Act under the One Big Beautiful Bill Act, signed into law on July 4, are surely relieved to see there...more
10/29/2025
/ Acquisitions ,
Affordable Care Act ,
Ambulatory Surgery Centers ,
Clinical Trials ,
Dentists ,
Healthcare ,
Home Health Care ,
Hospitals ,
Medicaid ,
Medical Research ,
Mergers ,
New Legislation ,
One Big Beautiful Bill Act ,
Physicians ,
Popular ,
Private Equity
The healthcare mergers and acquisitions (M&A) market remained active in Q2 2025, with several sectors including physician practice management (PPM), clinical research, and digital health experiencing continued investment and...more
7/30/2025
/ Acquisitions ,
Ambulatory Surgery Centers ,
Digital Health ,
EBITDA ,
Health Care Providers ,
Health Information Technologies ,
Healthcare ,
Healthcare Reform ,
Home Health Care ,
Hospice ,
Hospitals ,
Managed Care Contracts ,
Medical Research ,
Medicare Advantage ,
Mental Health ,
Mergers ,
Pharmaceutical Industry ,
Pharmacy Benefit Manager (PBM) ,
Physicians ,
Popular ,
Private Equity ,
Technology Sector ,
Value-Based Care
Oregon’s Senate Bill 951 (SB 951) was signed into law by Governor Kotek on June 9. While several states have recently proposed additional restrictions to the prohibition on the corporate practice of medicine, this law imposes...more
6/11/2025
/ Corporate Governance ,
Healthcare ,
Healthcare Reform ,
Legislative Agendas ,
New Legislation ,
Non-Compete Agreements ,
Oregon ,
Physicians ,
Shareholders ,
State and Local Government ,
State Legislatures
The healthcare mergers and acquisitions (M&A) market began 2025 with a slower start than expected given the easing headwinds and building momentum at the end of last year, with the number of deals reported in Q1 lower than...more
4/17/2025
/ Acquisitions ,
Ambulatory Surgery Centers ,
Clinical Trials ,
Digital Health ,
Health Information Technologies ,
Health Insurance ,
Healthcare ,
Home Health Care ,
Hospice ,
Hospitals ,
Investors ,
Managed Care Contracts ,
Mental Health ,
Mergers ,
Pharmaceutical Industry ,
Pharmacies ,
Pharmacy Benefit Manager (PBM) ,
Physicians ,
Popular ,
Private Equity ,
Regulatory Requirements ,
Value-Based Care
Since our recent updates, additional bills have been introduced that, if passed, will impact transactions across the healthcare industry. This alert contains an overview of legislation recently introduced in Connecticut and...more
Since our last update, new bills have been introduced that, if passed, would materially impact transactions across the health care industry or otherwise affect the corporate structure of or reporting by health care entities....more
Many state legislatures have recently convened for 2025 legislative sessions, and members have already proposed a significant number of bills that, if passed, would materially impact transactions and/or corporate structures...more
2/3/2025
/ Acquisitions ,
Corporate Governance ,
Disclosure Requirements ,
Healthcare ,
Investment ,
Investors ,
Mergers ,
New Legislation ,
Private Equity ,
Regulatory Requirements ,
State and Local Government ,
State Legislatures
On January 8, the governor of Massachusetts signed House Bill 5159 into law (Law). At a high level, the new Law expands Massachusetts’ existing health care transaction notice process and implements new reporting and oversight...more
As some packed the skis and headed to their favorite slopes this winter season, it is hard not to see the analogies to the healthcare private equity (PE) transaction market as we ring in the New Year. Much like the Northern...more
In the healthcare mergers and acquisitions (M&A) market, while deal volumes varied across different sectors, by and large the sure and steady pace of deal volume in Q2 continued into Q3. Moreover, several positive...more
10/21/2024
/ Acquisitions ,
California ,
Federal Reserve ,
Governor Newsom ,
Healthcare ,
Mergers ,
New Legislation ,
Physicians ,
Private Equity ,
Proposed Regulation ,
Regulatory Oversight ,
State and Local Government ,
State Legislatures
Bass, Berry & Sims, Deloitte and Harris Williams proudly co-hosted the 14th annual Health Care Investors Conference (HCIC) on October 9 as an associated event of the Nashville Healthcare Sessions conference....more
In April 2024, the Department of Health and Human Services (HHS) finalized revised regulations implementing Section 1557 of the Patient Protection and Affordable Care Act (ACA). The new, final Section 1557 regulations (2024...more
10/4/2024
/ Amended Rules ,
Compliance ,
Deadlines ,
Department of Health and Human Services (HHS) ,
Health Care Providers ,
Health Insurance ,
Healthcare ,
Healthcare Facilities ,
Medicare Part B ,
New Rules ,
Non-Discrimination Rules ,
OCR ,
Regulatory Requirements ,
Section 1557
On September 28, California Governor Newsom vetoed Assembly Bill 3129 (Bill), which would have created significant oversight of private investment in and management of certain healthcare transactions and arrangements in...more
9/30/2024
/ California ,
Filing Requirements ,
Governor Newsom ,
Governor Vetoes ,
Health Care Providers ,
Healthcare ,
Investment ,
Legislative Agendas ,
New Legislation ,
Private Equity ,
Regulatory Agenda ,
Regulatory Requirements
Although the U.S. healthcare industry has weathered the storm over the past couple of years, we may be reaching calmer waters in the coming months. Dry powder held by U.S. private equity investors has reached an all-time...more
8/15/2024
/ Acquisitions ,
Administrative Procedure Act ,
Corporate Transparency Act ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
Federal Trade Commission (FTC) ,
Filing Requirements ,
Final Rules ,
Government Agencies ,
Hart-Scott-Rodino Act ,
Healthcare ,
Investment ,
Investors ,
Loper Bright Enterprises v Raimondo ,
Mergers ,
Non-Compete Agreements ,
Private Equity ,
Regulatory Authority ,
Request For Information ,
SCOTUS ,
Statutory Authority ,
Statutory Interpretation
On June 26, the California Senate Health Committee passed Assembly Bill 3129 (Bill), which was further amended on June 27 and re-referred to the Committee on Judiciary. The following is a summary of the material changes made...more
Effective January 1, 2025, if enacted, California Assembly Bill 3129 (Bill) would grant sweeping power to the Attorney General by authorizing the Attorney General to approve, conditionally approve, or disapprove of certain...more
The recent Request for Information by the Federal Trade Commission (FTC), Department of Justice (DOJ) and Department of Health and Human Services (HHS) seeking input on the effects of private equity (PE) investment in the...more
Recognizing the ongoing impact of the cyberattack experienced by Change Healthcare/Optum on February 21, 2024, the Centers for Medicare & Medicaid Services (CMS) announced over the weekend that it will allow Part A providers...more